Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1179392 NEW YORK, NY
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,363,755
+$684,487 QoQ
Shares Held
1,239,778
+217.6% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 101 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. INO ranks #190 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in INO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,363,755 1,239,778
2026-03-31 $679,268 390,384
2025-12-31 $561,565 322,739
2025-09-30 $680,472 290,800
2025-06-30 $148,363 72,727
2025-03-31 $117,953 72,364
2024-09-30 $134,067 23,195
2024-06-30 $303,791 37,598
2024-03-31 $281,222 20,261
2023-12-31 $167,834 329,088
2023-09-30 $323,402 829,238
2023-06-30 $809,207 1,798,240
2022-12-31 $659,138 422,525
2022-09-30 $3,284,221 1,898,394
2022-06-30 $7,922,770 4,579,636
2022-03-31 $8,394,909 2,338,415